Assurgen Pharma headquarters details
- Street address
- 55-1-17/8/42 Flat No.308 Mvv Residency Venkojipalem Hb Colony Main Road
- City
- Visakhapatnam
- State / region
- State of Andhra Pradesh
- ZIP / postal code
- 530022
- Country
- India
- Founded
- 2013
- Website
- assurgenpharma.com
Location map
Open in Google MapsAll Assurgen Pharma office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Visakhapatnam HQ | State of Andhra Pradesh | India | Headquarters |
Showing the headquarters of 3 recorded locations. See every location in GraphIQ →
About Assurgen Pharma
Assurgen Pharma is headquartered in Visakhapatnam, State of Andhra Pradesh, India. Founded in 2013, the company has 3 recorded locations and employs approximately 125 people worldwide.
Where is Assurgen Pharma's main office?
Assurgen Pharma's main headquarters office is located at 55-1-17/8/42 Flat No.308 Mvv Residency Venkojipalem Hb Colony Main Road, Visakhapatnam, State of Andhra Pradesh 530022, India. This is the company's primary corporate address.
What does Assurgen Pharma do?
ASSURGEN PHARMA PRIVATE LIMITED is a mining & metals company based out of 55-1-17/8/42, FLAT NO.308, MVV RESIDENCY VENKOJIPALEM, HB COLONY MAIN ROAD, VISAKHAPATNAM, Andhra Pradesh, India.
Frequently asked questions
Where is Assurgen Pharma headquarters?
Assurgen Pharma's headquarters is located at 55-1-17/8/42 Flat No.308 Mvv Residency Venkojipalem Hb Colony Main Road, Visakhapatnam, State of Andhra Pradesh 530022, India.
How many offices does Assurgen Pharma have?
GraphIQ records 3 locations for Assurgen Pharma, as of October 2026.
What is Assurgen Pharma's corporate address?
The corporate headquarters address is 55-1-17/8/42 Flat No.308 Mvv Residency Venkojipalem Hb Colony Main Road, Visakhapatnam, State of Andhra Pradesh 530022, India.
When was Assurgen Pharma founded?
Assurgen Pharma was founded in 2013 and employs approximately 125 people.
How many employees does Assurgen Pharma have?
Assurgen Pharma has approximately 125 employees (GraphIQ estimate, 2026).